ConforMIS PT receives Investment Bank Analyst Rating Update
ConforMIS Inc (NASDAQ:CFMS) reported Q2 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.3 million versus the consensus...
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Oil & Gas, Industrials and Financials sectors led shares lower. At the close in NYSE, the Dow...
Despite Wall Street's current elevated volatility levels, seasoned investors have not stopped scouring for companies that have the potential to develop world-changing...
Conformis, Inc. CFMS was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands...
For Immediate ReleaseChicago, IL – March 25, 2020 – Stocks in this week’s article are Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) , ConforMIS Inc....
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.